Kai-Hendrik Peiffer (K-H Peiffer, K-H Peffer, Kai-Henrik Peiffer)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Topics

Circulating Tumor

Hepatitis B Virus

Cardiovascular Events

Top Venues

Alimentary pharmacology & therapeutics

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Claire Conche, Fabian Finkelmeier, Marina Pešić, Adele M Nicolas, Tim W Böttger, Kilian B Kennel, Dominic Denk, Fatih Ceteci, Kathleen Mohs, Esther Engel, Özge Canli, Yasamin Dabiri, Kai-Hendrik Peiffer, Stefan Zeuzem, Gabriela Salinas, Thomas Longerich, Huan Yang, Florian R Greten
Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut (2023)
Martin Sebastian Schulz, Jan Mengers, Wenyi Gu, Andreas Drolz, Philip G Ferstl, Alex Amoros, Frank Erhard Uschner, Nora Ackermann, Georg Guttenberg, Alexander Queck, Maximilian J Brol, Christiana Graf, Philipp Stoffers, Anna-Lena Laguna de la Vera, Carla Cremonese, Hans-Peter Erasmus, Martin W Welker, Achim Grünewaldt, Vincente Arroyo, Jörg Bojunga, Javier Fernandez, Stefan Zeuzem, Johannes Kluwe, Kai-Hendrik Peiffer, Christoph Welsch, Valentin Fuhrmann, Gernot Rohde, Jonel Trebicka
Pulmonary impairment independently determines mortality in critically ill patients with acute-on-chronic liver failure. Liver international : official journal of the International Association for the Study of the Liver (2022)
Michael Basic, Alica Kubesch, Lisa Kuhnhenn, Esra Görgülü, Fabian Finkelmeier, Julia Dietz, Mate Knabe, Victoria T Mücke, Marcus Maximilian Mücke, Annemarie Berger, Stefan Zeuzem, Christoph Sarrazin, Eberhard Hildt, Kai-Hendrik Peiffer
Not uncommon: HBV genotype G co-infections among healthy European HBV carriers with genotype A and E infection. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Esra Görgülü, Wenyi Gu, Jonel Trebicka, Victoria Therese Mücke, Marcus Maximilian Muecke, Mireen Friedrich-Rust, Joerg Bojunga, Stefan Zeuzem, Fabian Finkelmeier, Kai-Hendrik Peiffer
Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic? Gut 71 (5) (2021)
Bingfu Jiang, Kai-Hendrik Peiffer, Eberhard Hildt
Editorial: HBV-the naked truth? Authors' reply. Alimentary pharmacology & therapeutics 50 (8) (2020)
L Kuhnhenn, B Jiang, A Kubesch, S Zeuzem, C Sarrazin, E Hildt, Kai-Hendrik Peiffer
Editorial: HBsAg serum levels in HBeAg-negative chronic HBV infection-is it a matter of genotype? Authors' reply. Alimentary pharmacology & therapeutics 48 (1) (2019)
L Kuhnhenn, B Jiang, A Kubesch, S Zeuzem, C Sarrazin, E Hildt, Kai-Hendrik Peiffer
Letter: impact of HBV genotypes and PC/BCP mutations on serum HBsAg levels in Chinese HBeAg negative patients-Authors' reply. Alimentary pharmacology & therapeutics 48 (2) (2019)
Bingfu Jiang, Qingyan Wu, Lisa Kuhnhenn, Sami Akhras, Catrina Spengler, Klaus Boller, Kai-Hendrik Peiffer, Eberhard Hildt
Formation of semi-enveloped particles as a unique feature of a hepatitis B virus PreS1 deletion mutant. Alimentary pharmacology & therapeutics 50 (8) (2019)
L Kuhnhenn, B Jiang, A Kubesch, Johannes Vermehren, Viola Knop, S Susser, J Dietz, G Carra, Fabian Finkelmeier, G Grammatikos, S Zeuzem, C Sarrazin, E Hildt, Kai-Hendrik Peiffer
Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection. Alimentary pharmacology & therapeutics 47 (11) (2018)
V T Mücke, M M Mücke, Kai-Hendrik Peiffer, N Weiler, T M Welzel, C Sarrazin, S Zeuzem, A Berger, Johannes Vermehren
No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort. Alimentary pharmacology & therapeutics 46 (4) (2017)